Table 3 Proportion of CSU patients reporting quality of life impairment stratified by disease characteristics
Patients reporting sleep disturbance | Patients reporting emergency room visits | |
|---|---|---|
Males n = 13 (%) | 7 (54) | 5 (38) |
Females n = 59 (%) | 47 (80) | 24 (41) |
Duration of CSU n = 56 (%) | ||
6 weeks–23 months n = 17 | 13 (76) | 4 (24) |
24–47 months n = 9 | 7 (78) | 5 (56) |
48–71 months n = 11 | 6 (55) | 3 (27) |
72–95 months n = 5 | 5 (100) | 3 (60) |
96–119 months n = 5 | 4 (80) | 3 (60) |
120 months and greater n = 9 | 7 (78) | 5 (56) |
Patients with CSU Recurrence n = 22 (%) | 20 (91) | 9 (41) |
Angioedema n = 41 (%) | 32 (78) | 21 (51) |
Autoimmune/thyroid disease n = 14 (%) | 11 (79) | 8 (57) |